Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.

Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 2,104 matching trials from the live ClinicalTrials.gov search.
Filters: Condition: Food Clear all
Completed Phase 1 Interventional Accepts healthy volunteers

Pharmacokinetics of a Fixed Dose Combination of Canagliflozin/Metformin Coadministered With Food

NCT02039258
View directory record Official record
Conditions
Healthy Volunteers
Interventions
CANA/MET XR FDC
Drug
Lead sponsor
Janssen Research & Development, LLC
Industry
Eligibility
18 Years to 55 Years
Enrollment
24 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2014
U.S. locations
1
States / cities
Lincoln, Nebraska
Source: ClinicalTrials.gov public record
Updated Jul 14, 2014 · Synced Oct 22, 2026, 5:56 AM EDT
Completed No phase listed Observational Accepts healthy volunteers

The Good Tastes Study: Young Children's Food Acceptance Patterns

NCT04549233
View directory record Official record
Conditions
Food Neophobia, Parenting
Interventions
Not listed
Lead sponsor
University of Colorado, Denver
Other
Eligibility
6 Months to 24 Months
Enrollment
110 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2017 – 2018
U.S. locations
1
States / cities
Aurora, Colorado
Source: ClinicalTrials.gov public record
Updated Sep 16, 2020 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Nudging Nutrition With Monetary Incentives Environmental Cues

NCT02461108
View directory record Official record
Conditions
Obesity, Food Labeling, Health Behavior, Diet
Interventions
Subsidy, Tax, Tax and subsidy
Behavioral
Lead sponsor
Cornell University
Other
Eligibility
18 Years to 70 Years
Enrollment
221 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2010 – 2011
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Jun 3, 2015 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Not applicable Interventional Results available

A Double Blind Clinical Trial of DCS for Food Anxiety

NCT01996644
View directory record Official record
Conditions
Anorexia and Bulimia Nervosa
Interventions
Placebo vs Setraline, Setraline
Drug
Lead sponsor
Washington University School of Medicine
Other
Eligibility
14 Years to 65 Years
Enrollment
47 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2014
U.S. locations
1
States / cities
St Louis, Missouri
Source: ClinicalTrials.gov public record
Updated Mar 27, 2018 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

Delivering Health: Addressing Diabetes and Food Insecurity

NCT04831216
View directory record Official record
Conditions
Food Insecurity, Diabetes Mellitus, Type 2
Interventions
Type 2 Diabetes Appropriate Food Boxes + Diabetes Education
Behavioral
Lead sponsor
University of Arkansas
Other
Eligibility
18 Years and older
Enrollment
101 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2021 – 2023
U.S. locations
1
States / cities
Fayetteville, Arkansas
Source: ClinicalTrials.gov public record
Updated Jan 16, 2026 · Synced Oct 22, 2026, 5:56 AM EDT
Active, not recruiting Phase 1 Interventional

Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas

NCT05101148
View directory record Official record
Conditions
Neurofibromatosis Type 1
Interventions
Selumetinib
Drug
Lead sponsor
AstraZeneca
Industry
Eligibility
12 Years to 17 Years
Enrollment
24 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2028
U.S. locations
2
States / cities
Rochester, Minnesota • Akron, Ohio
Source: ClinicalTrials.gov public record
Updated Aug 20, 2026 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Phase 1 Interventional Accepts healthy volunteers

Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg

NCT00649012
View directory record Official record
Conditions
Healthy
Interventions
Pioglitazone HCl Tablets 45 mg, Actos® Tablets 45 mg
Drug
Lead sponsor
Mylan Pharmaceuticals Inc
Industry
Eligibility
18 Years and older
Enrollment
40 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2003
U.S. locations
1
States / cities
Fargo, North Dakota
Source: ClinicalTrials.gov public record
Updated Apr 24, 2024 · Synced Oct 22, 2026, 5:56 AM EDT
Recruiting Not applicable Interventional

Post Prandial Individual Responses to Different Foods

NCT06989164
View directory record Official record
Conditions
PreDiabetes, Diabetes Mellitus, Type 2, Healthy
Interventions
Post prandial testing
Other
Lead sponsor
Stanford University
Other
Eligibility
18 Years to 80 Years
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2028
U.S. locations
1
States / cities
Stanford, California
Source: ClinicalTrials.gov public record
Updated Dec 2, 2025 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

Study of Brain, Reward, and Kids' Eating

NCT05456516
View directory record Official record
Conditions
Obesity, Childhood, Eating Behavior
Interventions
Food Rating
Behavioral
Lead sponsor
Penn State University
Other
Eligibility
8 Years to 10 Years
Enrollment
76 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2023 – 2024
U.S. locations
1
States / cities
University Park, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Apr 13, 2026 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Phase 3 Interventional Results available

PALISADE Follow-on Study (ARC004)

NCT02993107
View directory record Official record
Conditions
Peanut Allergy
Interventions
AR101
Biological
Lead sponsor
Aimmune Therapeutics, Inc.
Industry
Eligibility
4 Years to 55 Years
Enrollment
388 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2016 – 2019
U.S. locations
47
States / cities
Tucson, Arizona • Little Rock, Arkansas • Mission Viejo, California + 39 more
Source: ClinicalTrials.gov public record
Updated Mar 17, 2022 · Synced Oct 22, 2026, 5:56 AM EDT
Completed No phase listed Observational

Cause of Unexplained Anaphylaxis

NCT00719719
View directory record Official record
Conditions
Idiopathic Anaphylaxis, Drug Anaphylaxis, Venom Anaphylaxis, Food Anaphylaxis
Interventions
Not listed
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Eligibility
13 Years to 75 Years
Enrollment
115 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
Started 2008
U.S. locations
1
States / cities
Bethesda, Maryland
Source: ClinicalTrials.gov public record
Updated Oct 2, 2026 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Phase 1 Interventional Accepts healthy volunteers

A Phase 1 Study of RO6806127 in Healthy Male Volunteers

NCT02196636
View directory record Official record
Conditions
Healthy Volunteer
Interventions
Placebo, RO6806127
Drug
Lead sponsor
Hoffmann-La Roche
Industry
Eligibility
18 Years to 45 Years · Male only
Enrollment
37 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2014 – 2015
U.S. locations
1
States / cities
Marlton, New Jersey
Source: ClinicalTrials.gov public record
Updated Nov 2, 2016 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Phase 2 Interventional

Dietary Interventions to Reduce Ultra-Processed Food Intake

NCT07226336
View directory record Official record
Conditions
Ultra-Processed Food Intake, Obesity & Overweight
Interventions
Introductory Educational Workshop, Standard Dietary Change (ON/OFF), Cognitive Dissonance Strategies (ON/OFF)
Behavioral
Lead sponsor
Oregon Research Institute
Other
Eligibility
18 Years to 70 Years
Enrollment
59 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026
U.S. locations
1
States / cities
Springfield, Oregon
Source: ClinicalTrials.gov public record
Updated Oct 15, 2026 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Not applicable Interventional

Grocery Prescription Program for Medicaid Adults With Hypertension or Type 2 Diabetes

NCT06033664
View directory record Official record
Conditions
Type 2 Diabetes Mellitus, Hypertension
Interventions
Fresh Funds
Behavioral
Lead sponsor
Alison Gustafson
Other
Eligibility
18 Years to 64 Years
Enrollment
50 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2024
U.S. locations
1
States / cities
Lexington, Kentucky
Source: ClinicalTrials.gov public record
Updated May 10, 2024 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

Impact of Warnings on Sugar-Sweetened Beverages

NCT04223687
View directory record Official record
Conditions
Dietary Habits
Interventions
Sugar-Sweetened Beverage Warning Label, Neutral label
Other
Lead sponsor
University of North Carolina, Chapel Hill
Other
Eligibility
18 Years and older
Enrollment
326 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2020 – 2021
U.S. locations
1
States / cities
Chapel Hill, North Carolina
Source: ClinicalTrials.gov public record
Updated Sep 1, 2021 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

CommunityRx-Hunger

NCT04171999
View directory record Official record
Conditions
Food Insecurity
Interventions
Community Rx-Hunger (CRx-H)
Other
Lead sponsor
University of Chicago
Other
Eligibility
Not listed
Enrollment
660 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2020 – 2023
U.S. locations
1
States / cities
Chicago, Illinois
Source: ClinicalTrials.gov public record
Updated Jul 28, 2026 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Phase 1 Interventional Accepts healthy volunteers

A Study of Merestinib (LY2801653) in Healthy Participants

NCT02779738
View directory record Official record
Conditions
Healthy
Interventions
Merestinib
Drug
Lead sponsor
Eli Lilly and Company
Industry
Eligibility
18 Years to 65 Years
Enrollment
24 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2016
U.S. locations
1
States / cities
Daytona Beach, Florida
Source: ClinicalTrials.gov public record
Updated Aug 29, 2016 · Synced Oct 22, 2026, 5:56 AM EDT
Terminated Phase 2 Interventional Results available

Dupilumab and Milk OIT for the Treatment of Cow's Milk Allergy

NCT04148352
View directory record Official record
Conditions
Allergies Food Milk
Interventions
Dupilumab, Placebo
Drug · Other
Lead sponsor
Andrew J Long, PharmD
Other
Eligibility
4 Years to 50 Years
Enrollment
33 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2025
U.S. locations
3
States / cities
Phoenix, Arizona • Scottsdale, Arizona • Palo Alto, California
Source: ClinicalTrials.gov public record
Updated Jan 7, 2026 · Synced Oct 22, 2026, 5:56 AM EDT
Terminated Not applicable Interventional

Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet

NCT03790436
View directory record Official record
Conditions
Epilepsy, Epilepsy Intractable, Seizures, Seizure Disorder, Ketogenic Dieting, Ketosis
Interventions
Betaquik
Dietary Supplement
Lead sponsor
University of Southern California
Other
Eligibility
18 Years and older
Enrollment
10 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2018 – 2021
U.S. locations
1
States / cities
Los Angeles, California
Source: ClinicalTrials.gov public record
Updated May 31, 2022 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Not applicable Interventional

Effect of Food Order on Postprandial Glucose Excursions in Pre-Diabetes

NCT03536364
View directory record Official record
Conditions
Obesity, Pre-Diabetes
Interventions
Food Order, Carbohydrate Last, Vegetables first
Behavioral
Lead sponsor
Weill Medical College of Cornell University
Other
Eligibility
30 Years to 65 Years
Enrollment
15 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated May 24, 2018 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Back to Basics: Addressing Childhood Obesity Through Traditional Foods in Alaska

NCT03601299
View directory record Official record
Conditions
Obesity
Interventions
Traditional food
Other
Lead sponsor
Alaska Native Tribal Health Consortium
Other
Eligibility
0 Years and older
Enrollment
416 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018 – 2023
U.S. locations
1
States / cities
Anchorage, Alaska
Source: ClinicalTrials.gov public record
Updated Jul 31, 2024 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Phase 1Phase 2 Interventional Results available

ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults

NCT04856865
View directory record Official record
Conditions
Food Allergy
Interventions
Low dose ADP101, High dose ADP101, Pooled Placebo
Biological
Lead sponsor
Alladapt Immunotherapeutics, Inc.
Industry
Eligibility
4 Years to 55 Years
Enrollment
73 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2022
U.S. locations
15
States / cities
Mission Viejo, California • Rolling Hills Estates, California • San Diego, California + 12 more
Source: ClinicalTrials.gov public record
Updated May 16, 2024 · Synced Oct 22, 2026, 5:56 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers

EXOMIND (BTL-699-2) for the Improvement in Willpower & Food Cravings

NCT07056036
View directory record Official record
Conditions
Self-Control, Food Cravings
Interventions
ActiveTreatment with BTL-699-2, Sham Treatment with BTL-699-2
Device
Lead sponsor
BTL Industries Ltd.
Industry
Eligibility
22 Years and older
Enrollment
51 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2024 – 2025
U.S. locations
4
States / cities
Denver, Colorado • Miami, Florida • Newburgh, Indiana + 1 more
Source: ClinicalTrials.gov public record
Updated Dec 10, 2025 · Synced Oct 22, 2026, 5:56 AM EDT
Terminated Phase 1 Interventional

Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy

NCT04950504
View directory record Official record
Conditions
Peanut Allergy
Interventions
CNP-201, Placebo
Drug
Lead sponsor
COUR Pharmaceutical Development Company, Inc.
Industry
Eligibility
16 Years to 55 Years
Enrollment
9 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2022
U.S. locations
9
States / cities
Scottsdale, Arizona • Mountain View, California • Rolling Hills Estates, California + 5 more
Source: ClinicalTrials.gov public record
Updated Sep 18, 2023 · Synced Oct 22, 2026, 5:56 AM EDT